Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: A case report [6]

Psychosomatics

Volumn 41, Issue 5, 2000, Pages 452-453

  Cozza, K L ^a   Swanton, E J ^a   Humphreys, C W ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; CARNITINE; COTRIMOXAZOLE; CYTOCHROME P450 INHIBITOR; DRUG METABOLITE; EFAVIRENZ; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; VALPROIC ACID;

ADULT; AFFECTIVE NEUROSIS; AMINO ACID BLOOD LEVEL; CASE REPORT; DRUG ACCUMULATION; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER PROTECTION; LIVER TOXICITY; MALE;

EID: 0033864161     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.41.5.452     Document Type: Letter

References (5)

1. L-carnitine supplementation in childhood epilepsy: Current perspectives
2. Valproic acid hepatic fatalities II. United States experience since 1984
3. Cytochrome P450-catalyzed formation of delta-4-VPA, a toxic metabolite of valproic acid
4. Valproate-induced hepatotoxicity protective effect of L-camitine supplementation
5. Valproic acid overdose and L-carnitine therapy